Cannabidiol: Blazin’ a New Trail in Seizure Disorders

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACPE Activity Number: 0204-0000-19-014-H01-P
Release Date: May 28, 2019
Expiration Date: May 28, 2022
Activity Type: Knowledge-based  
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Not Available   

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

This presentation will discuss the uses of cannabidiol in the treatment of Lennox-Gastaut syndrome or Dravet syndrome, possible drug interactions to that pharmacists should monitor for, considerations for the clinical and legal implications for the use of cannabidiol, and the pharmacist’s role in managing patients on cannabidiol.   


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This continuing pharmacy education activity is designed for pharmacists interested in learning about cannabidiol and its uses in seizure disorders.  

Learning Objectives

  • Identify medical indications for cannabidiol in cannabidiol-responsive seizure disorders.
  • Recognize the possible drug interactions with cannabidiol.
  • Describe the legal and clinical implications associated with cannabidiol.
  • Explain the pharmacist’s role in managing patients who use medical marijuana and cannabidiol products.

Schedule of Activities

  • Discuss the uses of and interactions with cannabidoil.
  • Provide examples of how the pharmacist can assist patients in need of cannabidoil.


  • Alexandria David, Pharm.D., PGY1 Pharmacy Resident, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN


In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.